Although this model did lead to development of AML, or less commonly acute lymphoid leukemia, there are known effects of Kmt2a haploinsufficiency during murine development that cannot be controlled using this method, such as anemia, thrombocytopenia, and decreased B-cells (62). This evidence concerns the gene KMT2A and acute myeloid leukemia.